- Home
- CPRX vs AVDX Comparison
CPRX vs AVDX Comparison
Compare CPRX & AVDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- AVDX
- Stock Information
- Founded
- CPRX 2002
- AVDX 2000
- Country
- CPRX United States
- AVDX United States
- Employees
- CPRX N/A
- AVDX N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- AVDX EDP Services
- Sector
- CPRX Health Care
- AVDX Technology
- Exchange
- CPRX Nasdaq
- AVDX Nasdaq
- Market Cap
- CPRX 2.6B
- AVDX 2.1B
- IPO Year
- CPRX 2006
- AVDX 2021
- Fundamental
- Price
- CPRX $20.82
- AVDX $9.96
- Analyst Decision
- CPRX Strong Buy
- AVDX Hold
- Analyst Count
- CPRX 5
- AVDX 14
- Target Price
- CPRX $33.20
- AVDX $9.73
- AVG Volume (30 Days)
- CPRX 1.6M
- AVDX 1.5M
- Earning Date
- CPRX 11-05-2025
- AVDX 11-05-2025
- Dividend Yield
- CPRX N/A
- AVDX N/A
- EPS Growth
- CPRX 183.96
- AVDX N/A
- EPS
- CPRX 1.65
- AVDX N/A
- Revenue
- CPRX $558,499,000.00
- AVDX $446,722,000.00
- Revenue This Year
- CPRX $16.51
- AVDX $5.52
- Revenue Next Year
- CPRX $9.58
- AVDX $9.64
- P/E Ratio
- CPRX $12.64
- AVDX N/A
- Revenue Growth
- CPRX 28.55
- AVDX 8.04
- 52 Week Low
- CPRX $19.05
- AVDX $6.61
- 52 Week High
- CPRX $26.58
- AVDX $11.68
- Technical
- Relative Strength Index (RSI)
- CPRX 58.08
- AVDX 56.73
- Support Level
- CPRX $19.05
- AVDX $9.89
- Resistance Level
- CPRX $21.07
- AVDX $9.98
- Average True Range (ATR)
- CPRX 0.59
- AVDX 0.02
- MACD
- CPRX 0.16
- AVDX -0.00
- Stochastic Oscillator
- CPRX 60.27
- AVDX 50.00
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About AVDX AvidXchange Holdings Inc.
AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.